DR Horton Inc (DHI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
DR Horton Inc stock (DHI) is currently trading at $133.12. DR Horton Inc PE ratio is 12.10. DR Horton Inc PS ratio (Price-to-Sales) is 1.16. Analyst consensus price target for DHI is $160.13. WallStSmart rates DHI as Hold.
- DHI PE ratio analysis and historical PE chart
- DHI PS ratio (Price-to-Sales) history and trend
- DHI intrinsic value — DCF, Graham Number, EPV models
- DHI stock price prediction 2025 2026 2027 2028 2029 2030
- DHI fair value vs current price
- DHI insider transactions and insider buying
- Is DHI undervalued or overvalued?
- DR Horton Inc financial analysis — revenue, earnings, cash flow
- DHI Piotroski F-Score and Altman Z-Score
- DHI analyst price target and Smart Rating
DR Horton Inc
📊 No data available
Try selecting a different time range
DHI Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · DR Horton Inc (DHI)
DHI trades 119% above its Graham fair value of $74.80, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
DR Horton Inc (DHI) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, price/sales. Concerns around revenue growth and eps growth. Fundamentals are solid but monitor weak areas for improvement.
DR Horton Inc (DHI) Key Strengths (5)
88.12% of shares held by major funds and institutions
Large-cap company with substantial market presence
Good growth relative to its price
Paying $1.16 for every $1 of annual revenue
Trading at 1.61x book value, attractively priced
Supporting Valuation Data
DR Horton Inc (DHI) Areas to Watch (5)
Revenue declining -9.50%, a shrinking business
Earnings declining -22.20%, profits shrinking
Thin operating margins with cost pressures present
Thin profit margins with limited profitability
Moderate profitability with room for improvement
DR Horton Inc (DHI) Detailed Analysis Report
Overall Assessment
This company scores 55/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.6/10) while 5 fall into concern territory (avg 2.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap, PEG Ratio. Valuation metrics including PEG Ratio (1.09), Price/Sales (1.16), Price/Book (1.61) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Operating Margin. Growth concerns include Revenue Growth at -9.50%, EPS Growth at -22.20%, which may limit upside. Profitability pressure is visible in Return on Equity at 13.50%, Operating Margin at 11.00%, Profit Margin at 9.95%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 13.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -9.50% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Institutional Own., Market Cap) and negatives (Revenue Growth, EPS Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
Compare DHI with Competitors
Top RESIDENTIAL CONSTRUCTION stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for DR Horton Inc (DHI) · CONSUMER CYCLICAL › RESIDENTIAL CONSTRUCTION
The Big Picture
DR Horton Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 33.5B with 10% decline year-over-year. Profit margins are thin at 9.9%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 1350.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 827M in free cash flow and 854M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 10% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can DR Horton Inc push profit margins above 15% as the business scales?
Sector dynamics: monitor RESIDENTIAL CONSTRUCTION industry trends, competitive moves, and regulatory changes that could impact DR Horton Inc.
Bottom Line
DR Horton Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(2 last 3 months)
| Insider | Type | Shares |
|---|---|---|
ODOM, ARON M. SVP, Controller and PAO | Sell | -260 |
| Insider | Type | Shares |
|---|---|---|
MURRAY, MICHAEL J EVP and COO | Sell | -7,060 |
Data sourced from SEC Form 4 filings
Last updated: 6:49:34 AM
About DR Horton Inc(DHI)
NYSE
CONSUMER CYCLICAL
RESIDENTIAL CONSTRUCTION
USA
D.R. Horton, Inc. is a home construction company incorporated in Delaware and headquartered in Arlington, Texas.